当前位置: X-MOL 学术Cancer › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Mind the gap: Gendered publication trends in oncology.
Cancer ( IF 6.2 ) Pub Date : 2020-03-25 , DOI: 10.1002/cncr.32818
Nicole H Dalal 1 , Fumiko Chino 2 , Hannah Williamson 3 , Georgia M Beasley 4 , April K S Salama 5 , Manisha Palta 2
Affiliation  

BACKGROUND Investigating scientific publication trends in the field of oncology may highlight opportunities for improved representation, mentorship, collaboration, and advancement for women. METHODS We conducted a bibliometric analysis of Annals of Surgical Oncology; Cancer; International Journal of Radiation Oncology, Biology, Physics (IJROBP); JAMA Oncology; and Journal of Clinical Oncology in 1990, 2000, 2010, and 2017. Full name and degree credentials per author role (ie, first or senior author), article type, publication year, and citation metrics were collected. First names were used to identify author gender. RESULTS Across 9189 articles, female representation rose between 1990 and 2017 (first authors: 17.7% in 1990, 36.6% in 2017; senior authors: 11.7% in 1990, 28.5% in 2017). For the 50 most cited articles per year, women comprised a smaller percent of first (26.5%) and senior (19.9%) authors. The average citation count was higher for male first (44.8 per article) and senior (47.1) authors compared to female first (39.7) and senior (44.1) authors. With male senior authors, the first author was more likely male (71.4% male; 25.0% female); with female senior authors, first authors were 50.2% male and 47.6% female. IJROBP had the lowest total female representation among first (25.1%) and senior (16.7%) authors. Women had more MDs with Masters degrees, whereas men held more MDs only and more MDs with PhDs. CONCLUSION Despite positive trends, substantial gendered differences in oncology publications persist. Fostering more women in oncology research will benefit female representation at many levels of academia and improve productivity, collaboration, and recruitment, especially in technical fields such as radiation and surgical oncology.

中文翻译:

注意差距:肿瘤学中的性别出版趋势。

背景技术调查肿瘤学领域中的科学出版趋势可能会凸显改善女性代表,指导,合作和地位提高的机会。方法我们对《外科肿瘤学年鉴》进行了文献计量分析。癌症; 国际放射肿瘤学,生物学,物理学杂志(IJROBP);JAMA肿瘤学; 以及分别在1990年,2000年,2010年和2017年出版的《临床肿瘤学杂志》。收集了每个作者角色(即第一作者或资深作者),文章类型,发表年份和引用指标的全名和学位证书。名字被用来识别作者的性别。结果在9189篇文章中,女性代表人数在1990年至2017年之间有所上升(第一作者:1990年为17.7%,2017年为36.6%;资深作者:1990年为11.7%,2017年为28.5%)。对于每年被引用最多的50篇文章,在第一作者(26.5%)和资深作者(19.9%)中,女性所占比例较小。男性第一作者(每篇文章44.8)和资深作者(47.1)的平均被引计数高于女性第一(39.7)和资深(44.1)的作者。在男性高级作者中,第一作者更有可能是男性(男性71.4%;女性25.0%);在女性资深作者中,第一作者为男性的50.2%和女性的47.6%。在第一作者(25.1%)和资深作者(16.7%)中,IJROBP的总女性代表最低。女性拥有硕士学位的医学博士数量更多,而男性仅拥有博士学位的医学博士数量更多。结论尽管有积极的趋势,肿瘤学出版物中仍然存在明显的性别差异。在肿瘤学研究中培养更多女性将使许多学术界的女性代表受益,并提高生产力,协作,
更新日期:2020-03-25
down
wechat
bug